Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma

Authors

Farrukh Afaq, University of Alabama at Birmingham
Sumit Agarwal, University of Alabama at Birmingham
Prachi Bajpai, University of Alabama at Birmingham
Sameer Al Diffalha, University of Alabama at Birmingham
Hyung-Gyoon Kim, University of Alabama at Birmingham
Shajan Peter, University of Alabama at Birmingham
Moh'd Khushman, Washington University School of Medicine in St. Louis
Subhash C Chauhan, The University of Texas Rio Grande Valley
Priyabrata Mukherjee, University of Oklahoma Health Sciences Center
Sooryanarayana Varambally, University of Alabama at Birmingham
Upender Manne, University of Alabama at Birmingham

Journal

Neoplasia

Publication Date

1-1-2024

Volume

47

First Page

100951

Document Type

Open Access Publication

DOI

10.1016/j.neo.2023.100951

Rights and Permissions

Afaq F, Agarwal S, Bajpai P, Diffalha SA, Kim HG, Peter S, Khushman M, Chauhan SC, Mukherjee P, Varambally S, Manne U. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Neoplasia. 2024 Jan;47:100951. doi: 10.1016/j.neo.2023.100951. © 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).

Recommended Citation

Afaq, Farrukh; Agarwal, Sumit; Bajpai, Prachi; Diffalha, Sameer Al; Kim, Hyung-Gyoon; Peter, Shajan; Khushman, Moh'd; Chauhan, Subhash C; Mukherjee, Priyabrata; Varambally, Sooryanarayana; and Manne, Upender, "Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma." Neoplasia. 47, 100951 (2024).
https://digitalcommons.wustl.edu/oa_4/3846

Additional Links

Supplemental material is available for this article at publisher site.